دورية أكاديمية
أعرض في EDS

Comparative study on alginate/chitosan microcapsules and Montanide ISA 61 as vaccine adjuvants in mice.

التفاصيل البيبلوغرافية
العنوان: Comparative study on alginate/chitosan microcapsules and Montanide ISA 61 as vaccine adjuvants in mice.
المؤلفون: Silva LA; Departamento de Clínica e Cirurgia Veterinária, Escola de Veterinária, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Souza MF; Departamento de Patologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Carvalho TP; Departamento de Clínica e Cirurgia Veterinária, Escola de Veterinária, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Santana CH; Departamento de Clínica e Cirurgia Veterinária, Escola de Veterinária, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Guedes AC; Departamento de Clínica e Cirurgia Veterinária, Escola de Veterinária, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Oliveira JBS; Departamento de Clínica e Cirurgia Veterinária, Escola de Veterinária, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., de Lima PA; Departamento de Clínica e Cirurgia Veterinária, Escola de Veterinária, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Nogueira PRA; Departamento de Clínica e Cirurgia Veterinária, Escola de Veterinária, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., de Mello Brandão H; Embrapa Gado de Leite, Juiz de Fora, Minas Gerais, Brazil., da Paixão TA; Departamento de Patologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil., Santos RL; Departamento de Clínica e Cirurgia Veterinária, Escola de Veterinária, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
المصدر: PloS one [PLoS One] 2024 Apr 04; Vol. 19 (4), pp. e0298117. Date of Electronic Publication: 2024 Apr 04 (Print Publication: 2024).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science
مواضيع طبية MeSH: Chitosan* , Vaccines* , Mineral Oil*, Animals ; Mice ; Sheep ; Adjuvants, Vaccine ; Capsules ; Adjuvants, Immunologic/pharmacology ; Immunoglobulin G ; Mice, Inbred BALB C
مستخلص: Selection of adjuvant to be combined with the antigen is an extremely important point for formulating effective vaccines. The aim of this study was to evaluate reactogenicity, levels of IgM, IgG and subclasses (IgG1, IgG2b and IgG3), and protection elicited by vaccine formulations with association of chitosan coated alginate or Montanide ISA 61 with γ-irradiated Brucella ovis. The alginate/chitosan biopolymers as well as the Montanide ISA 61 emulsion elicited intense and long-lasting local response, especially when associated with the antigen. However, Montanide ISA 61 induced less intense reactogenicity when compared to alginate/chitosan. Furthermore, γ-irradiated B. ovis with Montanide ISA 61 induced higher levels of IgG2b an important marker of cellular immune response. In conclusion, Montanide ISA 61 resulted in milder reactogenicity when compared to the alginate/chitosan, while it induced a high IgG2b/IgG1 ratio compatible with a Th1 profile response.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2024 Silva et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
References: Curr Pharm Des. 2019;25(11):1312-1334. (PMID: 31465282)
Molecules. 2018 Oct 16;23(10):. (PMID: 30332830)
Vet Parasitol. 2010 Sep 20;172(3-4):221-8. (PMID: 20541870)
Iran J Vet Res. 2016 Winter;17(1):8-12. (PMID: 27656222)
Vet World. 2015 Oct;8(10):1189-98. (PMID: 27047016)
Vaccine. 2022 Jul 30;40(32):4617-4624. (PMID: 35750543)
PLoS One. 2016 Nov 15;11(11):e0166582. (PMID: 27846274)
Vaccine. 2017 Mar 7;35(10):1417-1423. (PMID: 28187951)
Int J Biol Macromol. 2021 Apr 15;176:567-577. (PMID: 33581203)
BMC Microbiol. 2018 May 30;18(1):45. (PMID: 29848308)
Clin Diagn Lab Immunol. 2003 Nov;10(6):1141-6. (PMID: 14607880)
Vaccine. 2018 Sep 5;36(37):5591-5599. (PMID: 30077483)
NPJ Vaccines. 2019 Sep 24;4:39. (PMID: 31583123)
Nat Med. 2013 Dec;19(12):1597-608. (PMID: 24309663)
FEMS Microbiol Rev. 2021 Jan 8;45(1):. (PMID: 33016322)
Exp Appl Acarol. 2017 Jul;72(3):303-315. (PMID: 28752480)
J Comp Pathol. 2009 Feb-Apr;140(2-3):149-57. (PMID: 19111839)
Drug Discov Today. 2008 Jul;13(13-14):596-600. (PMID: 18598915)
PLoS One. 2014 Sep 08;9(9):e106891. (PMID: 25198669)
Expert Rev Vaccines. 2015 Jan;14(1):37-53. (PMID: 25262982)
J Immunol Methods. 1998 Mar 15;212(2):187-92. (PMID: 9672206)
Infect Immun. 2003 Oct;71(10):5750-5. (PMID: 14500496)
Trends Immunol. 2019 Mar;40(3):197-211. (PMID: 30745265)
Infect Immun. 2023 May 16;91(5):e0006223. (PMID: 37129522)
Expert Rev Vaccines. 2002 Jun;1(1):111-8. (PMID: 12908518)
PLoS One. 2014 Sep 16;9(9):e107180. (PMID: 25225910)
Vet Immunol Immunopathol. 2002 Nov;90(1-2):1-10. (PMID: 12406650)
المشرفين على المادة: 0 (Adjuvants, Vaccine)
0 (Monatide (IMS 3015))
9012-76-4 (Chitosan)
0 (Capsules)
0 (Adjuvants, Immunologic)
0 (Vaccines)
0 (Immunoglobulin G)
8020-83-5 (Mineral Oil)
تواريخ الأحداث: Date Created: 20240404 Date Completed: 20240408 Latest Revision: 20240408
رمز التحديث: 20240408
مُعرف محوري في PubMed: PMC10994407
DOI: 10.1371/journal.pone.0298117
PMID: 38573916
قاعدة البيانات: MEDLINE
الوصف
تدمد:1932-6203
DOI:10.1371/journal.pone.0298117